Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Celgene Corporation CELG

Healthcare Drug Manufacturers - Major
Celgene is a biopharmaceutical firm that discovers, develops, and markets therapeutics for the treatment of cancer and immunological diseases. Celgene markets Thalomid and Pomalyst to treat multiple myeloma and Revlimid, a less toxic thalidomide derivative, to treat myelodysplastic syndromes, multiple myeloma, and mantle cell lymphoma. Acquisitions have brought MDS drug Vidaza, T-cell lymphoma... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CELG)

FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Bristol-Myers Squibb Company - BMY

PR Newswire November 18, 2021

BRISTOL MYERS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Bristol-Myers Squibb Company - BMY

PR Newswire November 17, 2021

Investor Alert: Class Action Lawsuit Filed Against Bristol-Myers Squibb Company

Newsfile October 28, 2021

CELG Investor Alert: Class Action Lawsuit Filed Against Bristol-Myers Squibb Company

Newsfile October 23, 2021

NASDAQ: CELG Investor Notice: Update in Lawsuit against Celgene Corporation announced by Shareholders Foundation

ACCESSWIRE IA January 7, 2020

NexImmune Appoints Sol Barer as Chairman of the Board of Directors

GlobeNewswire December 16, 2019

Amgen Completes Acquisition Of Otezla® (apremilast)

PR Newswire November 21, 2019

Celgene Announces Plans to Transfer Listing of Celgene's Contingent Value Rights Following Closing of Acquisition by Bristol-Myers Squibb

Business Wire November 20, 2019

Thermo Fisher Scientific Set to Join S&P 100; ServiceNow to Join S&P 500

PR Newswire November 19, 2019
View More News ››

Opinion & Analysis (NDAQ:CELG)

Why the election is not as relevant to drug stocks as you might believe

The Life Sciences Report November 4, 2016

Diffusion Pharmaceuticals takes aim at brain cancer: CEO David Kalergis

The Life Sciences Report April 1, 2016

Circling the globe for uncommon biotech opportunities

The Life Sciences Report February 18, 2016

Biotech Bears Spark Good Vibes For These ETFs

Benzinga.com  October 6, 2015

BTIG's Hartaj Singh's advice for biotech investors: 'hold your powder' 'til winter

Gail Dutton October 1, 2015

CAR T-cell therapeutics: Alan Leong of BioWatch looks beyond the buzz for solid early-stage plays

Gail Dutton September 10, 2015
View More Opinion ››

Bullboard Posts (NDAQ:CELG)

Seeking another celgene

Seeking a penny stock that could explode into a several hundred dollar stock .theralase v.tlt may fit the bill v.tlt is a undiscovered...
goregil - February 10, 2019

Old Japanese Technique Ichimoku soon may give buy signal

Check Out Ceglene Corporation (CELG) Technical Analysis with old Japanese technique Ichimoku
Ichimek - July 6, 2018

RE:Buybacks?

The market has decided right or wrong they made a bad purchase with Juno, so if that was 9 bill. wasted, the market has now taken 18 bill...
paths - May 22, 2018

Buybacks?

Is Mgmt going to step in and do anything as this thing loses 1-2% daily?
JOHNNYBOYO1 - May 18, 2018

Why CELG Keeps Falling: BluSignals Indicators

Many traders and investors continue to anticipate a turn in direction for this biotech company.  However, there are several pieces...
BluSignals - May 7, 2018

ARQL 3 bux/share DO invest in a REAL INVESTMENT! Bye CELG

ArQule to Present Data at the 2018 American Association for Cancer Research (AACR) Annual Meeting ARQL | March...
IckySticky - April 4, 2018
View more Bullboard ››

Star Diamond Corp

Star Diamond Corp

Star Diamond Corporation is a Canada-based company engaged in the acquisition, exploration and development of mineral ...
View More »